Table 7.
Effect of dietary treatment and period on plasma glucose (mg/dL), non-esterified fatty acid (µmol/L), urea (mg/dL), and amino acid concentrations (µmol/L)
| Treatmenta | Period | P-value | ||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Item | NC | BZA | BC50 | AGP | 1 | 2 | SEMc | Treatment | Period | Treatment × period |
| Glucose | 147 | 142 | 149 | 142 | 167 | 123 | 14 | 0.96 | <0.001 | 0.90 |
| NEFA | 90 | 101 | 86 | 104 | 87 | 103 | 16 | 0.68 | 0.18 | 0.52 |
| PUN | 9.5*,† | 8.2† | 9.5*,† | 11.4* | 8.0 | 12.3 | 1.1 | 0.08 | <0.001 | 0.27 |
| NEAAc | ||||||||||
| Ala | 358 | 364 | 367 | 359 | 430 | 294 | 15 | 0.98 | <0.001 | 0.88 |
| Arg | 89 | 108 | 91 | 101 | 91 | 104 | 12 | 0.18 | 0.06 | 0.92 |
| Asn | 59 | 72 | 60 | 70 | 64 | 66 | 5 | 0.16 | 0.64 | 0.72 |
| Asp | 33 | 37 | 30 | 34 | 38 | 29 | 3 | 0.23 | <0.001 | 0.74 |
| Cysd | 183† | 199*,† | 190*,† | 208* | 190 | 200 | 8 | 0.004 | 0.04 | 0.34 |
| Glu | 236 | 228 | 236 | 220 | 276 | 184 | 40 | 0.90 | <0.001 | 0.39 |
| Gln | 314 | 286 | 285 | 317 | 315 | 287 | 26 | 0.25 | 0.06 | 0.09 |
| Gly | 616* | 492† | 608*,† | 684* | 606 | 594 | 45 | 0.001 | 0.69 | 0.94 |
| Pro | 159 | 173 | 164 | 175 | 170 | 165 | 8 | 0.49 | 0.56 | 0.90 |
| Ser | 97† | 99*,† | 98† | 119* | 98 | 108 | 6 | 0.02 | 0.09 | 0.94 |
| Tyr | 121 | 136 | 114 | 128 | 107 | 142 | 9 | 0.15 | <0.001 | 0.81 |
| EAAc | ||||||||||
| His | 45 | 52 | 46 | 49 | 49 | 47 | 4 | 0.21 | 0.40 | 0.19 |
| Ile | 82 | 92 | 79 | 90 | 90 | 82 | 4 | 0.06 | 0.05 | 0.68 |
| Leu | 106 | 124 | 108 | 125 | 114 | 117 | 6 | 0.04 | 0.63 | 0.36 |
| Lys | 115 | 151 | 131 | 138 | 137 | 130 | 22 | 0.10 | 0.53 | 0.74 |
| Met | 38 | 44 | 43 | 43 | 39 | 45 | 5 | 0.40 | 0.06 | 0.76 |
| Phe | 48† | 56* | 49*,† | 53*,† | 53 | 50 | 2 | 0.02 | 0.12 | 0.56 |
| Thr | 121† | 171* | 135*,† | 153*,† | 138 | 152 | 12 | 0.03 | 0.23 | 0.41 |
| Val | 108 | 129 | 104 | 128 | 107 | 128 | 10 | 0.03 | 0.006 | 0.17 |
| Other AAc | ||||||||||
| Cit | 28*,† | 29*,† | 25† | 32* | 27 | 30 | 2 | 0.02 | 0.04 | 0.97 |
| Hcyd | 27 | 25 | 22 | 31 | 22 | 31 | 3 | 0.19 | 0.002 | 0.65 |
| Orn | 66 | 72 | 64 | 70 | 63 | 73 | 5 | 0.66 | 0.04 | 0.91 |
| Tau | 125 | 124 | 106 | 148 | 102 | 149 | 26 | 0.30 | 0.003 | 0.10 |
| NEAA | 2,265 | 2,191 | 2,245 | 2,414 | 2,385 | 2,172 | 79 | 0.24 | 0.01 | 0.85 |
| EAA | 662† | 818† | 692*,† | 778*,† | 731 | 744 | 36 | 0.01 | 0.71 | 0.39 |
| BCAA | 296 | 345 | 291 | 343 | 311 | 327 | 19 | 0.03 | 0.33 | 0.33 |
aPigs were fed experimental diets at weaning (28 d age) for 21 d. Treatments: NC: negative control (no additive); BZA: benzoic acid (0.60%); BC50: Benzocal-50 (0.20%); AGP: antibiotic growth promoter (Carbadox, 50 ppm). Period: period 1 = 7 d; period 2 = 14 d.
bMaximum value for the standard error of the mean.
cAmino acids were analyzed in plasma following deproteinization and derivatization with AQC; tryptophan-AQC derivative was not able to be detected by fluorescence.
dCys and Hcy were analyzed in plasma following disulfide bond reduction, deproteinization, and derivatization with 4-(aminosulfonyl)-7-fluoro-2,1,3-benzoxadiazole.
*,†Means without a common superscript differ after Tukey multiple comparison test, P < 0.05.
Abbreviations: AA: amino acid; Ala: alanine; AQC: 6-aminoquinolyl-N-hydroxysuccinimidyl carbamate; Arg: arginine; Asn: asparagine; BCAA: branched-chain amino acid; Cit: citrulline; Cys: cysteine; EAA: essential amino acid; Glu: glutamate; Gln: glutamine; Gly: glycine; His: histidine; Hcy: homocysteine; Ile: isoleucine; Leu: leucine; Lys: lysine; Met: methionine; NEAA: non-essential amino acid; NEFA: non-esterified fatty acid; Orn: ornithine; Phe: phenylalanine; Pro: proline; PUN: plasma urea nitrogen; Ser: serine; Tau: taurine; Thr: threonine; Tyr: tyrosine; Val: valine.